Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 112

1.

Treating hepatocellular carcinoma progression following first-line sorafenib: therapeutic options and clinical observations.

He AR, Goldenberg AS.

Therap Adv Gastroenterol. 2013 Nov;6(6):447-58. doi: 10.1177/1756283X13498540.

PMID:
24179481
[PubMed]
Free PMC Article
2.

The antiangiogenic ceiling in hepatocellular carcinoma: does it exist and has it been reached?

Abou-Alfa GK, Venook AP.

Lancet Oncol. 2013 Jun;14(7):e283-8. doi: 10.1016/S1470-2045(13)70161-X.

PMID:
23725711
[PubMed - indexed for MEDLINE]
3.

Emerging targeted strategies in advanced hepatocellular carcinoma.

Finn RS.

Semin Liver Dis. 2013 Feb;33 Suppl 1:S11-9. doi: 10.1055/s-0033-1333632. Epub 2013 Mar 1. Review.

PMID:
23457035
[PubMed - indexed for MEDLINE]
4.

Molecularly targeted therapies for hepatocellular carcinoma: sorafenib as a stepping stone.

Kim HY, Park JW.

Dig Dis. 2011;29(3):303-9. doi: 10.1159/000327563. Epub 2011 Aug 9. Review.

PMID:
21829021
[PubMed - indexed for MEDLINE]
5.

Systemic treatment and targeted therapy in patients with advanced hepatocellular carcinoma.

Tazi el M, Essadi I, M'rabti H, Touyar A, Errihani PH.

N Am J Med Sci. 2011 Apr;3(4):167-75. doi: 10.4297/najms.2011.3167.

PMID:
22540086
[PubMed]
Free PMC Article
6.

Beyond sorafenib: novel targeted therapies for advanced hepatocellular carcinoma.

Zhu AX.

Expert Opin Investig Drugs. 2010 May;19(5):663-72. doi: 10.1517/13543781003767426. Review.

PMID:
20367287
[PubMed - indexed for MEDLINE]
7.

Molecularly targeted therapy for advanced hepatocellular carcinoma in 2012: current status and future perspectives.

Zhu AX.

Semin Oncol. 2012 Aug;39(4):493-502. doi: 10.1053/j.seminoncol.2012.05.014. Review.

PMID:
22846866
[PubMed - indexed for MEDLINE]
8.

Current and Future Treatment Strategies for Patients with Advanced Hepatocellular Carcinoma: Role of mTOR Inhibition.

Finn RS.

Liver Cancer. 2012 Nov;1(3-4):247-56. doi: 10.1159/000343839. Review.

PMID:
24159589
[PubMed]
Free PMC Article
9.

Role of anti-angiogenesis therapy in the management of hepatocellular carcinoma: The jury is still out.

Sun H, Zhu MS, Wu WR, Shi XD, Xu LB.

World J Hepatol. 2014 Dec 27;6(12):830-5. doi: 10.4254/wjh.v6.i12.830. Review.

PMID:
25544869
[PubMed]
Free PMC Article
10.

Advanced unresectable hepatocellular carcinoma: new biologics as fresh ammunition or clues to disease understanding?

Dekervel J, van Pelt J, Verslype C.

Curr Opin Oncol. 2013 Jul;25(4):409-16. doi: 10.1097/CCO.0b013e3283621074. Review.

PMID:
23680714
[PubMed - indexed for MEDLINE]
11.

Mechanisms of resistance to sorafenib and the corresponding strategies in hepatocellular carcinoma.

Zhai B, Sun XY.

World J Hepatol. 2013 Jul 27;5(7):345-52. doi: 10.4254/wjh.v5.i7.345.

PMID:
23898367
[PubMed]
Free PMC Article
12.

New molecularly targeted therapies against advanced hepatocellular carcinoma: From molecular pathogenesis to clinical trials and future directions.

Chuma M, Terashita K, Sakamoto N.

Hepatol Res. 2014 Dec 4. doi: 10.1111/hepr.12459. [Epub ahead of print]

PMID:
25472913
[PubMed - as supplied by publisher]
13.
14.

Consensus on the current use of sorafenib for the treatment of hepatocellular carcinoma.

Peck-Radosavljevic M, Greten TF, Lammer J, Rosmorduc O, Sangro B, Santoro A, Bolondi L.

Eur J Gastroenterol Hepatol. 2010 Apr;22(4):391-8. doi: 10.1097/MEG.0b013e328333df23.

PMID:
19940784
[PubMed - indexed for MEDLINE]
15.
16.

Targeted systemic therapies for hepatocellular carcinoma: clinical perspectives, challenges and implications.

Frenette C, Gish R.

World J Gastroenterol. 2012 Feb 14;18(6):498-506. doi: 10.3748/wjg.v18.i6.498. Review.

PMID:
22363115
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Targeted therapy of hepatocellular cancer.

Wysocki PJ.

Expert Opin Investig Drugs. 2010 Feb;19(2):265-74. doi: 10.1517/13543780903514110. Review.

PMID:
20074016
[PubMed - indexed for MEDLINE]
18.

Sorafenib: a review of its use in advanced hepatocellular carcinoma.

Keating GM, Santoro A.

Drugs. 2009;69(2):223-40. doi: 10.2165/00003495-200969020-00006. Review.

PMID:
19228077
[PubMed - indexed for MEDLINE]
19.

Sorafenib for the treatment of advanced hepatocellular carcinoma.

Connock M, Round J, Bayliss S, Tubeuf S, Greenheld W, Moore D.

Health Technol Assess. 2010 May;14 Suppl 1:17-21. doi: 10.3310/hta14Suppl1/03. Review.

PMID:
20507799
[PubMed - indexed for MEDLINE]
Free Article
20.

Hepatocellular carcinoma: the place of new medical therapies.

Peck-Radosavljevic M.

Therap Adv Gastroenterol. 2010 Jul;3(4):259-67. doi: 10.1177/1756283X10362278.

PMID:
21180607
[PubMed]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk